Clinical And Health-Economic Criteria for the Assessment of New Immune-Oncologic Drugs in Spain.
نویسندگان
چکیده
*Other members of the Scienti c Committee: Alegre EJ, Clopés A, Garrido P, Isla D, Lamas MJ, Martín M, Martín-Algarra S, Massuti B, Piulats JM 1 Facultad de Terapia Ocupacional, Logopedia y Enfermería de Talavera de la Reina. Toledo. Universidad Castilla-La Mancha, Spain. 2 Facultad de Ciencias Jurídicas y Sociales de Toledo. Universidad Castilla-La Mancha, Spain. 3 Facultad de Economía y Empresa. Universidad de Murcia, Spain. 4 Medical Department, Bristol-Myers Squibb, Spain. This study was sponsored by Bristol-Myers Squibb. Professional medical writing and editorial assistance were provided by Laura Ruiz at Ogilvy CommonHealth and was funded by Bristol-Myers Squibb. The authors would like to thank the Panel of Experts for their participation during the study.
منابع مشابه
Administrative Process and Criteria Ranking for Drug Entering Health Insurance List in Iran-TOPSIS-Based Consensus Model
The purposes of our study were to identify a drug entry process, collect, and prioritize criteria for selecting drugs for the list of basic health insurance commitments to prepare an “evidence based reimbursement eligibility plan” in Iran.The 128 noticeable criteria were found when studying the health insurance systems of developed countries. Four parts (involving criteria) formed the first que...
متن کاملAdministrative Process and Criteria Ranking for Drug Entering Health Insurance List in Iran-TOPSIS-Based Consensus Model
The purposes of our study were to identify a drug entry process, collect, and prioritize criteria for selecting drugs for the list of basic health insurance commitments to prepare an “evidence based reimbursement eligibility plan” in Iran.The 128 noticeable criteria were found when studying the health insurance systems of developed countries. Four parts (involving criteria) formed the first que...
متن کاملبررسی پوشش بیمه‌ای دارو در ایران در مقایسه با کشورهای منتخب
Introduction: in Iran, the compilation council of drug, having an advisory role, is responsible to cover medicine costs for health insurances. Health Insurance High Council also acts as the final decision maker about the admission of new drugs. This article studies how new drugs in Iran's health insurances are covered compared with some selected countries. Methods: After collecting drug accep...
متن کاملThe assessment of patient’s satisfaction about medicinal plants in Isfahan
Background & Aim: Reason destroyer and side effectories some chemical drugs , many pations would to use medicinal plants , on the other hand new medicine nevereless cost and powerful ,have problems for treat some maladies specically chronic maladies. We at this article surveid satisfactoryُ s pations of herbal medicine to compare with new therapeutic ways and defined that further pations for wha...
متن کاملRisk Assessment of Investments with Fuzzy Efficiency Indicators for Oil and Gas Production Industry
In the process of investment decision making, next to financial indicators many other aspects of investment projects are increasingly often considered. This leads to the multi-criteria evaluation of a project. The advantage of multi-criteria methods is the ability to take into account all (not only financial) aspects of the attractiveness of an investment project. The selection of criteria of p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
دوره 18 7 شماره
صفحات -
تاریخ انتشار 2015